153 related articles for article (PubMed ID: 7760107)
1. PET: brain tumor biochemistry.
Roelcke U
J Neurooncol; 1994; 22(3):275-9. PubMed ID: 7760107
[TBL] [Abstract][Full Text] [Related]
2. PET of malignant cerebral tumors after interstitial brachytherapy. Demonstration of metabolic activity and correlation with clinical outcome.
Valk PE; Budinger TF; Levin VA; Silver P; Gutin PH; Doyle WK
J Neurosurg; 1988 Dec; 69(6):830-8. PubMed ID: 2848111
[TBL] [Abstract][Full Text] [Related]
3. Fluorine-18-FDG PET and iodine-123-IMT SPECT in the evaluation of brain tumors.
Weber W; Bartenstein P; Gross MW; Kinzel D; Daschner H; Feldmann HJ; Reidel G; Ziegler SI; Lumenta C; Molls M; Schwaiger M
J Nucl Med; 1997 May; 38(5):802-8. PubMed ID: 9170450
[TBL] [Abstract][Full Text] [Related]
4. Glucose uptake by gliomas after treatment. A positron emission tomographic study.
Rozental JM; Levine RL; Nickles RJ; Dobkin JA
Arch Neurol; 1989 Dec; 46(12):1302-7. PubMed ID: 2556096
[TBL] [Abstract][Full Text] [Related]
5. Non-invasive grading of primary brain tumours: results of a comparative study between SPET with 123I-alpha-methyl tyrosine and PET with 18F-deoxyglucose.
Woesler B; Kuwert T; Morgenroth C; Matheja P; Palkovic S; Schäfers M; Vollet B; Schäfers K; Lerch H; Brandau W; Samnick S; Wassmann H; Schober O
Eur J Nucl Med; 1997 Apr; 24(4):428-34. PubMed ID: 9096095
[TBL] [Abstract][Full Text] [Related]
6. Independent thallium-201 accumulation and fluorine-18-fluorodeoxyglucose metabolism in glioma.
Oriuchi N; Tomiyoshi K; Inoue T; Ahmad K; Sarwar M; Tokunaga M; Suzuki H; Watanabe N; Hirano T; Horikoshi S; Shibasaki T; Tamura M; Endo K
J Nucl Med; 1996 Mar; 37(3):457-62. PubMed ID: 8772644
[TBL] [Abstract][Full Text] [Related]
7. Regional methionine and glucose uptake in high-grade gliomas: a comparative study on PET-guided stereotactic biopsy.
Goldman S; Levivier M; Pirotte B; Brucher JM; Wikler D; Damhaut P; Dethy S; Brotchi J; Hildebrand J
J Nucl Med; 1997 Sep; 38(9):1459-62. PubMed ID: 9293808
[TBL] [Abstract][Full Text] [Related]
8. Alteration of blood-brain barrier in human brain tumors: comparison of [18F]fluorodeoxyglucose, [11C]methionine and rubidium-82 using PET.
Roelcke U; Radü EW; von Ammon K; Hausmann O; Maguire RP; Leenders KL
J Neurol Sci; 1995 Sep; 132(1):20-7. PubMed ID: 8523026
[TBL] [Abstract][Full Text] [Related]
9. Serial PET studies of human cerebral malignancy with [1-11C]putrescine and [1-11C]2-deoxy-D-glucose.
Hiesiger E; Fowler JS; Wolf AP; Logan J; Brodie JD; McPherson D; MacGregor RR; Christman DR; Volkow ND; Flamm E
J Nucl Med; 1987 Aug; 28(8):1251-61. PubMed ID: 3039083
[TBL] [Abstract][Full Text] [Related]
10. In vivo metabolism of childhood posterior fossa tumors and primitive neuroectodermal tumors before and after treatment.
Holthoff VA; Herholz K; Berthold F; Widemann B; Schröder R; Neubauer I; Heiss WD
Cancer; 1993 Aug; 72(4):1394-403. PubMed ID: 8339230
[TBL] [Abstract][Full Text] [Related]
11. The in vivo metabolic pattern of low-grade brain gliomas: a positron emission tomographic study using 18F-fluorodeoxyglucose and 11C-L-methylmethionine.
Derlon JM; Petit-Taboué MC; Chapon F; Beaudouin V; Noël MH; Creveuil C; Courtheoux P; Houtteville JP
Neurosurgery; 1997 Feb; 40(2):276-87; discussion 287-8. PubMed ID: 9007859
[TBL] [Abstract][Full Text] [Related]
12. Serial FDG-PET studies in the prediction of survival in patients with primary brain tumors.
Schifter T; Hoffman JM; Hanson MW; Boyko OB; Beam C; Paine S; Schold SC; Burger PC; Coleman RE
J Comput Assist Tomogr; 1993; 17(4):509-61. PubMed ID: 8392523
[TBL] [Abstract][Full Text] [Related]
13. Enhanced detection of brain tumors by [18F]fluorodeoxyglucose PET with glucose loading.
Ishizu K; Sadato N; Yonekura Y; Nishizawa S; Magata Y; Tamaki N; Tsuchida T; Okazawa H; Tanaka F; Miyatake S
J Comput Assist Tomogr; 1994; 18(1):12-5. PubMed ID: 8282860
[TBL] [Abstract][Full Text] [Related]
14. Positron emission tomography using [18F] fluorodeoxyglucose in brain tumors. A powerful diagnostic and prognostic tool.
Di Chiro G
Invest Radiol; 1987 May; 22(5):360-71. PubMed ID: 3496318
[No Abstract] [Full Text] [Related]
15. [Evaluation of brain tumors using positron emission tomography].
Schober O; Meyer GJ
Radiologe; 1992 Jun; 32(6):282-9. PubMed ID: 1322547
[TBL] [Abstract][Full Text] [Related]
16. The in vivo metabolic pattern of low-grade brain gliomas: a positron emission tomographic study using f-18-fluorodeoxyglucose and c-11-L-methylmethionine.
Hölzer T
Neurosurgery; 1998 May; 42(5):1200-1. PubMed ID: 9588575
[No Abstract] [Full Text] [Related]
17. Prediction of brain tumor therapy response by PET.
Blasberg RG
J Neurooncol; 1994; 22(3):281-6. PubMed ID: 7760108
[TBL] [Abstract][Full Text] [Related]
18. [Positron emission tomographic evaluations on hemodynamics and glucose metabolism of brain tumors and perifocal edematous tissues].
Mizukawa N; Hino A; Imahori Y; Tenjin H; Yano I; Yoshino E; Hirakawa K; Yamashita M; Oki F; Nakahashi H
No To Shinkei; 1989 Mar; 41(3):251-8. PubMed ID: 2787998
[TBL] [Abstract][Full Text] [Related]
19. A comparative study of thallium-201 SPET, carbon-11 methionine PET and fluorine-18 fluorodeoxyglucose PET for the differentiation of astrocytic tumours.
Sasaki M; Kuwabara Y; Yoshida T; Nakagawa M; Fukumura T; Mihara F; Morioka T; Fukui M; Masuda K
Eur J Nucl Med; 1998 Sep; 25(9):1261-9. PubMed ID: 9724375
[TBL] [Abstract][Full Text] [Related]
20. Use of positron emission tomography (PET) in stereotactic conditions for brain biopsy.
Pirotte B; Goldman S; Bidaut LM; Luxen A; Stanus E; Brucher JM; Balériaux D; Brotchi J; Levivier M
Acta Neurochir (Wien); 1995; 134(1-2):79-82. PubMed ID: 7668134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
